JOHN WALTER SCOTT
Medical Practice in Portland, OR
License number
Pennsylvania MD040728L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Portland, OR 97201
Pennsylvania
Pennsylvania
Personal information
See more information about JOHN WALTER SCOTT at radaris.comName
Address
Phone
3530 SE 84Th Ave APT 516, Portland, OR 97266
531 Fairfield Ave, Eugene, OR 97402
5304 E Evans Creek Rd, Rogue River, OR 97537
52 Shenango Blvd, Farrell, PA 16121
534 Oak Valley Loop, Winchester, OR 97495
Professional information
Lead Window Installer At Nw Insulation &Amp; Weatherization
Position:
Carpenter at OHI Construction
Location:
Portland, Oregon Area
Industry:
Construction
Work:
OHI Construction
- Portland, Oregon since Aug 2012
-
Carpenter
Market Contractors
Apr 2012 - Oct 2012
-
Industrial Cabinet Maker
The Remodel Group
Oct 2010 - Jan 2012
-
Builder/Remodeler
The Home Depot Home Services
2008 - 2009
-
kitchen and bathroom installer
Education:
University of Colorado Boulder 2002 - 2007
Bachelor's, Arts Wyoming High School 1998 - 2002
Bachelor's, Arts Wyoming High School 1998 - 2002
John Scott - Portland, OR
Education:
Oregon Polytechnical Institute - Portland, OR
GED in general
GED in general
Owner, Av Solutions
Position:
Owner at AV Solutions
Location:
Portland, Oregon Area
Industry:
Security and Investigations
Work:
AV Solutions
-
Owner
Student At Alaska Pacific University
Location:
Portland, Oregon Area
Industry:
Computer Games
Education:
Alaska Pacific University 2008 - 2013
Arts And Crafts Professional
Location:
Portland, Oregon Area
Industry:
Arts and Crafts
John Scott, Portland OR
Work:
Coldwell Banker
Portland
(503) 224-7325
Portland
(503) 224-7325
Calcineurin Inhibitory Compounds And Anchoring Protein To Induce Il-2 Gene Expression
US Patent:
5744354, Apr 28, 1998
Filed:
Mar 15, 1995
Appl. No.:
8/404731
Inventors:
Robert Owen Lockerbie - Kirkland WA
John D. Scott - Portland OR
Vincent M. Coghlan - Portland OR
Monique L. Howard - Seattle WA
W. Michael Gallatin - Mercer Island WA
John D. Scott - Portland OR
Vincent M. Coghlan - Portland OR
Monique L. Howard - Seattle WA
W. Michael Gallatin - Mercer Island WA
Assignee:
ICOS Corporation - Bothell WA
The State of Oregon, acting by and through the Oregon State Board of
Higher Education, and on behalf of Oregon Health Sciences University - Portland OR
The State of Oregon, acting by and through the Oregon State Board of
Higher Education, and on behalf of Oregon Health Sciences University - Portland OR
International Classification:
A61K 3800, C12N 508
US Classification:
435325
Abstract:
The present invention provides compositions and methods useful for isolating calcineurin as well as inhibiting calcineurin activity. The compositions are peptides that contain regions that are homologous to calcineurin-binding regions of AKAP 79. Also provided are methods for determining if a cell contains a calcineurin-binding and PKA-binding anchoring protein that are useful for identifying additional proteins that bind both calcineurin and PKA. Another aspect of the present invention is methods for enhancing expression of interleukin 2 by T cells.
Protein Binding Fragments Of Gravin
US Patent:
5741890, Apr 21, 1998
Filed:
Dec 19, 1996
Appl. No.:
8/769309
Inventors:
John D. Scott - Portland OR
J. Brian Nauert - Portland OR
Theresa M. Klauck - Portland OR
J. Brian Nauert - Portland OR
Theresa M. Klauck - Portland OR
Assignee:
Oregon Health Sciences University - Portland OR
International Classification:
C07K 1400
US Classification:
530300
Abstract:
The present invention generally relates to protein binding fragments of gravin and polynucleotides encoding these fragments. The protein binding fragments include fragments which bind to the Type II regulatory subunit of cAMP-dependent protein kinase or protein kinase C. This invention further provides antibodies to the protein binding fragments and assays for identifying compounds which modulate the binding of gravin to the binding protein.
Inhibitors Of Protein Kinase A Anchoring
US Patent:
2008024, Oct 9, 2008
Filed:
Sep 26, 2005
Appl. No.:
11/575966
Inventors:
Cathrine Rein Carlson - Oslo, NO
Kjetil Tasken - Rykkinn, NO
John Scott - Portland OR, US
Kjetil Tasken - Rykkinn, NO
John Scott - Portland OR, US
International Classification:
A61K 35/12, C12N 9/12, C07K 16/18, C12N 15/11, C12P 21/04, A61P 37/00, C12Q 1/48, C12N 5/06, A61K 38/43, A61K 31/70
US Classification:
424 9321, 435194, 5303879, 536 232, 435 691, 435375, 424 945, 514 44, 435 15
Abstract:
A PKA I anchoring disrupting molecule or AKAP mimic, wherein said molecule or mimic is a polypeptide which comprises the following amino acid sequence: XXXY A XXL A XXXI XXXXX(sequence (1)) or a peptidomimetic or analogue thereof is provided. Also provided are antibodies to the molecule, nucleic acid molecules comprising a sequence encoding the molecule and pharmaceutical compositions. A method of altering the PKA type I signalling pathway in a cell by administration of the anchoring disruption molecule or AKAP mimic, in particular to treat immunosuppressive disorders, proliferative diseases or autoimmune diseases is also provided.
John Scott
Location:
Portland, Oregon Area
Industry:
Insurance